Is a complete ADIL research report available?

No complete published report is available for Adial Pharmaceuticals, Inc. (ADIL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · USD

$5.07

+1.36 (+36.7%)· Recorded snapshot

Market cap	13.3M
Net income (ttm)	-57.8M
EPS (ttm)	-$22.0
Shares out	2.6M
Volume	79,982
Beta	1.50

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -57.8M
EPS (ttm): -$22.0
Market cap: 13.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001513525
Company name	Adial Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	00688A304
Earnings date	2026-11-12
Earnings time	amc
Employees	5
Employees change	1
Employees growth	25%
Enterprise value	$-15.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Biotechnology
IPO date	2018-07-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US00688A3041
Last 10-K release date	2026-03-05
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-02-06
Last stock split type	Reverse
Market cap	$13.3M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$5.07
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ADIL
U.S. state	Virginia
Website	https://www.adial.com

Metric

Value

Amount currency

USD

CIK code

0001513525

Company name

Adial Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

00688A304

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

Employees growth

25%

Enterprise value

$-15.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

Industry

Biotechnology

IPO date

2018-07-30

Is primary listing

Yes

Is SPAC

ISIN number

US00688A3041

Last 10-K release date

2026-03-05

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-02-06

Last stock split type

Reverse

Market cap

$13.3M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$5.07

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ADIL

U.S. state

Virginia

Website

https://www.adial.com

Metric	Value
Earnings yield	-434.16%
FCF / EV yield	58.69%
FCF yield	-114.27%
P/B ratio	62.45x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-434.16%

FCF / EV yield

58.69%

FCF yield

-114.27%

P/B ratio

62.45x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-11.6M
ROA	-40.02%
ROA (5Y)	-108.94%
ROCE	-47.95%
ROE	-2,011.64%
ROE (5Y)	-304.29%
ROIC	-249.96%

Metric

Value

Profit per employee

$-11.6M

ROA

-40.02%

ROA (5Y)

-108.94%

ROCE

-47.95%

ROE

-2,011.64%

ROE (5Y)

-304.29%

ROIC

-249.96%

Metric	Value
EPS growth years	4
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$565
EBIT	$-11.5M
EBITDA	$-11.5M
EPS	$-22.01
FCF per share	$-4.24
Financing cash flow	$28.6M
Free cash flow	$-11.1M
Free cash flow minus SBC	$-11.7M
Investing cash flow	$5.3M
Net cash flow	$22.8M
Net income	$-57.8M
Operating cash flow minus SBC	$-11.7M
Operating income	$-11.5M
Stock-based compensation	$600,200

Metric

Value

Depreciation and amortization

$565

EBIT

$-11.5M

EBITDA

$-11.5M

EPS

$-22.01

FCF per share

$-4.24

Financing cash flow

$28.6M

Free cash flow

$-11.1M

Free cash flow minus SBC

$-11.7M

Investing cash flow

$5.3M

Net cash flow

$22.8M

Net income

$-57.8M

Operating cash flow minus SBC

$-11.7M

Operating income

$-11.5M

Stock-based compensation

$600,200

Metric	Value
Book value per share	$-14.61
Debt / equity	0
Interest coverage	-5.56
Long-term assets	$244,000
Long-term liabilities	$23.8M
Net cash (debt)	$28.7M
Net cash / market cap	294.72%
Net cash growth	385.41%
Net debt / equity	-184.05
Piotroski F-Score	2
Shareholders' equity	$156,000
Tangible book value	$-38.4M
Tangible book value per share	$-14.62
Total assets	$29.1M
Total cash	$28.7M
Total debt	$0
Total liabilities	$28.9M
WACC	12.52%

Metric

Value

Book value per share

$-14.61

Debt / equity

Interest coverage

-5.56

Long-term assets

$244,000

Long-term liabilities

$23.8M

Net cash (debt)

$28.7M

Net cash / market cap

294.72%

Net cash growth

385.41%

Net debt / equity

-184.05

Piotroski F-Score

Shareholders' equity

$156,000

Tangible book value

$-38.4M

Tangible book value per share

$-14.62

Total assets

$29.1M

Total cash

$28.7M

Total debt

Total liabilities

$28.9M

WACC

12.52%

Metric	Value
Current assets	$28.8M
Current liabilities	$5.1M
Current ratio	5.63
Net working capital	$-5M
Quick ratio	5.61
Working capital	$23.7M

Metric

Value

Current assets

$28.8M

Current liabilities

$5.1M

Current ratio

5.63

Net working capital

$-5M

Quick ratio

5.61

Working capital

$23.7M

Metric	Value
Buyback yield / dilution	-791.51%
Dividend yield	0%
Shareholder yield	-791.51%

Metric

Value

Buyback yield / dilution

-791.51%

Dividend yield

Shareholder yield

-791.51%

Metric	Value
150-day SMA	$3.21
1D price change	36.66%
1M price change	13.27%
1M total return	13.27%
1W price change	25.13%
1W total return	25.13%
1Y price change	-47.6%
1Y return CAGR	-47.63%
1Y total return	-47.6%
20-day SMA	$3.84
200-day SMA	$3.24
3M price change	70.11%
3M total return	70.11%
3Y price change	-90.58%
3Y return CAGR	-54.49%
3Y total return	-90.58%
50-day SMA	$4.74
50-day SMA vs 200-day SMA	50over200
52-week high	$9.53
52-week high date	2025-10-28
52-week low	$1.31
52-week low date	2026-05-15
5Y price change	-99.76%
5Y return CAGR	-70.18%
5Y total return	-99.76%
6M price change	206.41%
6M total return	206.41%
All-time high	$5,900.00
All-time high date	2019-01-15
All-time low	$1.31
All-time low date	2026-05-15
Average true range (ATR)	$0.47
Average volume	33.7K
Beta (1Y)	1.7
Beta (2Y)	1.44
Beta (5Y)	1.5
Change from 52-week high	-46.77%
Change from 52-week low	287.02%
Change from all-time high	-99.92%
Change from all-time low	264.89%
Change from open	27.07%
Day's gap	7.55%
Dollar volume	$405,509
High price	$5.07
Low price	$3.89
Monthly RSI	33.55
Open price	$3.99
Position in 52-week range	100%
Premarket change	10.47%
Premarket close	$3.71
Premarket price	$4.10
Previous close	$3.71
Price vs 150-day SMA	48.86%
Price vs 20-day SMA	24.61%
Price vs 200-day SMA	47.76%
Price vs 50-day SMA	0.78%
Relative volume	2.37
RSI	60.15
Sharpe ratio	-0.14
Sharpe ratio (3Y)	-0
Sharpe ratio (5Y)	-0.4
Sortino ratio	-0.16
Sortino ratio (3Y)	0.05
Sortino ratio (5Y)	-0.69
Volume	80K
Weekly RSI	54.15
YTD price change	-13.09%
YTD total return	-13.09%

Metric

Value

150-day SMA

$3.21

1D price change

36.66%

1M price change

13.27%

1M total return

13.27%

1W price change

25.13%

1W total return

25.13%

1Y price change

-47.6%

1Y return CAGR

-47.63%

1Y total return

-47.6%

20-day SMA

$3.84

200-day SMA

$3.24

3M price change

70.11%

3M total return

70.11%

3Y price change

-90.58%

3Y return CAGR

-54.49%

3Y total return

-90.58%

50-day SMA

$4.74

50-day SMA vs 200-day SMA

50over200

52-week high

$9.53

52-week high date

2025-10-28

52-week low

$1.31

52-week low date

2026-05-15

5Y price change

-99.76%

5Y return CAGR

-70.18%

5Y total return

-99.76%

6M price change

206.41%

6M total return

206.41%

All-time high

$5,900.00

All-time high date

2019-01-15

All-time low

$1.31

All-time low date

2026-05-15

Average true range (ATR)

$0.47

Average volume

33.7K

Beta (1Y)

1.7

Beta (2Y)

1.44

Beta (5Y)

1.5

Change from 52-week high

-46.77%

Change from 52-week low

287.02%

Change from all-time high

-99.92%

Change from all-time low

264.89%

Change from open

27.07%

Day's gap

7.55%

Dollar volume

$405,509

High price

$5.07

Low price

$3.89

Monthly RSI

33.55

Open price

$3.99

Position in 52-week range

100%

Premarket change

10.47%

Premarket close

$3.71

Premarket price

$4.10

Previous close

$3.71

Price vs 150-day SMA

48.86%

Price vs 20-day SMA

24.61%

Price vs 200-day SMA

47.76%

Price vs 50-day SMA

0.78%

Relative volume

2.37

RSI

60.15

Sharpe ratio

-0.14

Sharpe ratio (3Y)

-0

Sharpe ratio (5Y)

-0.4

Sortino ratio

-0.16

Sortino ratio (3Y)

0.05

Sortino ratio (5Y)

-0.69

Volume

80K

Weekly RSI

54.15

YTD price change

-13.09%

YTD total return

-13.09%

Metric	Value
Float	2.1M
Float percentage	80.4%
Shares change (QoQ)	91.66%
Shares change (YoY)	791.51%
Shares held by insiders	5.38%
Shares held by institutions	5.17%
Shares outstanding	2.6M
Short % of float	8.68%
Short % of shares	6.98%
Short ratio	3.8 days

Metric

Value

Float

2.1M

Float percentage

80.4%

Shares change (QoQ)

91.66%

Shares change (YoY)

791.51%

Shares held by insiders

5.38%

Shares held by institutions

5.17%

Shares outstanding

2.6M

Short % of float

8.68%

Short % of shares

6.98%

Short ratio

3.8 days

Adial Pharmaceuticals, Inc. (ADIL)

Price

Financial snapshot

Fair-value bridge

Latest news · ADIL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADIL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ADIL

Frequently asked questions